Exploring Potential Referral Pathways for Renal Artery Denervation and Developing a Centre of Excellence in Ireland
Abstract Arterial hypertension is one of the most significant and prevalent risk factors for cardiovascular disease. Despite widespread awareness of the condition, as well as a multitude of available antihypertensive drug classes, rates of uncontrolled hypertension remain high on a global scale. Frequently, poor compliance with anti-hypertensive medication plays a big role in patients’ inability to attain adequate blood pressure control. In individuals with resistant and/or uncontrolled hypertension, renal denervation is an emerging device-based therapy that has shown to be efficacious and safe in reducing blood pressure in several sham controlled trials. Additionally, it represents a treatment option for patients intolerant to oral pharmacotherapy. University Hospital Galway has been performing renal denervation procedures over the past number of years within multicentre, international sham-controlled trials and registries. Representing a novel and emerging antihypertensive treatment option, sources of referral for renal denervation are diverse and multiple; thus, there is an unmet need for standardised referral structures in Ireland. Herein, we review current and developing referral pathways for renal denervation at our institution, and discuss streamlined patient management and requirements to establish a centre of excellence..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
SN comprehensive clinical medicine - 6(2024), 1 vom: 16. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Leahy, Niall [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Centre of excellence |
|---|
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1007/s42399-024-01647-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055185118 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055185118 | ||
| 003 | DE-627 | ||
| 005 | 20240317064653.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240317s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s42399-024-01647-9 |2 doi | |
| 035 | |a (DE-627)SPR055185118 | ||
| 035 | |a (SPR)s42399-024-01647-9-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Leahy, Niall |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Exploring Potential Referral Pathways for Renal Artery Denervation and Developing a Centre of Excellence in Ireland |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Abstract Arterial hypertension is one of the most significant and prevalent risk factors for cardiovascular disease. Despite widespread awareness of the condition, as well as a multitude of available antihypertensive drug classes, rates of uncontrolled hypertension remain high on a global scale. Frequently, poor compliance with anti-hypertensive medication plays a big role in patients’ inability to attain adequate blood pressure control. In individuals with resistant and/or uncontrolled hypertension, renal denervation is an emerging device-based therapy that has shown to be efficacious and safe in reducing blood pressure in several sham controlled trials. Additionally, it represents a treatment option for patients intolerant to oral pharmacotherapy. University Hospital Galway has been performing renal denervation procedures over the past number of years within multicentre, international sham-controlled trials and registries. Representing a novel and emerging antihypertensive treatment option, sources of referral for renal denervation are diverse and multiple; thus, there is an unmet need for standardised referral structures in Ireland. Herein, we review current and developing referral pathways for renal denervation at our institution, and discuss streamlined patient management and requirements to establish a centre of excellence. | ||
| 650 | 4 | |a Renal denervation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Hypertension |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Guidelines |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Referral pathways |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Centre of excellence |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Wagener, Max |4 aut | |
| 700 | 1 | |a Shahzad, Shirjeel |4 aut | |
| 700 | 1 | |a Murphy, Darragh |4 aut | |
| 700 | 1 | |a McMorrow, Amy |4 aut | |
| 700 | 1 | |a Coen, Eileen |4 aut | |
| 700 | 1 | |a Sharif, Ruth |4 aut | |
| 700 | 1 | |a Sharif, Faisal |0 (orcid)0000-0003-0086-4864 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t SN comprehensive clinical medicine |d Springer International Publishing, 2019 |g 6(2024), 1 vom: 16. März |w (DE-627)SPR038535785 |w (DE-600)2947252-0 |x 2523-8973 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2024 |g number:1 |g day:16 |g month:03 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s42399-024-01647-9 |z kostenfrei |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2024 |e 1 |b 16 |c 03 | ||